{"pmid":32365190,"title":"TREC-COVID: Rationale and Structure of an Information Retrieval Shared Task for COVID-19.","text":["TREC-COVID: Rationale and Structure of an Information Retrieval Shared Task for COVID-19.","TREC-COVID is an information retrieval (IR) shared task initiated to support clinicians and clinical research during the COVID-19 pandemic. IR for pandemics breaks many normal assumptions, which can be seen by examining nine important basic IR research questions related to pandemic situations. TREC-COVID differs from traditional IR shared task evaluations with special considerations for the expected users, IR modality considerations, topic development, participant requirements, assessment process, relevance criteria, evaluation metrics, iteration process, projected timeline, and the implications of data use as a post-task test collection. This article describes how all these were addressed for the particular requirements of developing IR systems under a pandemic situation. Finally, initial participation numbers are also provided, which demonstrate the tremendous interest the IR community has in this effort.","J Am Med Inform Assoc","Roberts, Kirk","Alam, Tasmeer","Bedrick, Steven","Demner-Fushman, Dina","Lo, Kyle","Soboroff, Ian","Voorhees, Ellen","Wang, Lucy Lu","Hersh, William R","32365190"],"abstract":["TREC-COVID is an information retrieval (IR) shared task initiated to support clinicians and clinical research during the COVID-19 pandemic. IR for pandemics breaks many normal assumptions, which can be seen by examining nine important basic IR research questions related to pandemic situations. TREC-COVID differs from traditional IR shared task evaluations with special considerations for the expected users, IR modality considerations, topic development, participant requirements, assessment process, relevance criteria, evaluation metrics, iteration process, projected timeline, and the implications of data use as a post-task test collection. This article describes how all these were addressed for the particular requirements of developing IR systems under a pandemic situation. Finally, initial participation numbers are also provided, which demonstrate the tremendous interest the IR community has in this effort."],"journal":"J Am Med Inform Assoc","authors":["Roberts, Kirk","Alam, Tasmeer","Bedrick, Steven","Demner-Fushman, Dina","Lo, Kyle","Soboroff, Ian","Voorhees, Ellen","Wang, Lucy Lu","Hersh, William R"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365190","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/jamia/ocaa091","topics":["General Info"],"weight":1,"_version_":1666138496083951616,"score":9.490897,"similar":[{"pmid":32435829,"title":"COVID-19 Outbreak: Infection Control and Management Protocol for Vascular and Interventional Radiology Departments-Consensus Document.","text":["COVID-19 Outbreak: Infection Control and Management Protocol for Vascular and Interventional Radiology Departments-Consensus Document.","COVID-19 (SARS-CoV-2 virus) pandemic was recently declared by the WHO as a global health emergency. A group of interventional radiology senior experts developed a consensus document for infection control and management of patients with COVID-19 in interventional radiology (IR) departments. This consensus statement has been brought together at short notice with the help of different protocols developed by governmental entities and scientific societies to be adapted to the current reality and needs of IR Departments. Recommendations are the specific strategies to follow in IR departments, preventive measures and regulations, step by step for donning and doffing personal protective equipment, specific IR procedures which can not be delayed, and aerosol-generating procedures in IR with COVID-19 patients. It is advisable with this document to be adapted to local workplace policies.","Cardiovasc Intervent Radiol","De Gregorio, Miguel A","Guirola, Jose A","Magallanes, Mariano","Palmero, Julio","Pulido, Juan M","Blazquez, Javier","Cobos, Jorge","Abadal, Jose M","Mendez, Santiago","Perez-Lafuente, Mercedes","Piquero Micheto, Maria C","Gregorio, Abel","Lonjedo, Elena","Moreno, Teresa","Pulpeiro, Jose R","Sampere, Jaume","Esteban, Enrique","Munoz, Jose J","Bosch, Jordi","Alvarez-Arranz, Enrique","Gonzalez, Jimena","Gelabert, Arantxa","Urbano, Jose","32435829"],"abstract":["COVID-19 (SARS-CoV-2 virus) pandemic was recently declared by the WHO as a global health emergency. A group of interventional radiology senior experts developed a consensus document for infection control and management of patients with COVID-19 in interventional radiology (IR) departments. This consensus statement has been brought together at short notice with the help of different protocols developed by governmental entities and scientific societies to be adapted to the current reality and needs of IR Departments. Recommendations are the specific strategies to follow in IR departments, preventive measures and regulations, step by step for donning and doffing personal protective equipment, specific IR procedures which can not be delayed, and aerosol-generating procedures in IR with COVID-19 patients. It is advisable with this document to be adapted to local workplace policies."],"journal":"Cardiovasc Intervent Radiol","authors":["De Gregorio, Miguel A","Guirola, Jose A","Magallanes, Mariano","Palmero, Julio","Pulido, Juan M","Blazquez, Javier","Cobos, Jorge","Abadal, Jose M","Mendez, Santiago","Perez-Lafuente, Mercedes","Piquero Micheto, Maria C","Gregorio, Abel","Lonjedo, Elena","Moreno, Teresa","Pulpeiro, Jose R","Sampere, Jaume","Esteban, Enrique","Munoz, Jose J","Bosch, Jordi","Alvarez-Arranz, Enrique","Gonzalez, Jimena","Gelabert, Arantxa","Urbano, Jose"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435829","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00270-020-02493-7","keywords":["covid-19","covid-19 patient management","coronavirus infection control","health workers","interventional radiologist safety","interventional radiology staff safety","interventional suite infection control","prevention of infection control"],"topics":["Prevention"],"weight":1,"_version_":1667521393650040832,"score":309.89703},{"pmid":32349382,"title":"An Overview of Signal Processing Techniques for Remote Health Monitoring Using Impulse Radio UWB Transceiver.","text":["An Overview of Signal Processing Techniques for Remote Health Monitoring Using Impulse Radio UWB Transceiver.","Non-invasive remote health monitoring plays a vital role in epidemiological situations such as SARS outbreak (2003), MERS (2015) and the recently ongoing outbreak of COVID-19 because it is extremely risky to get close to the patient due to the spread of contagious infections. Non-invasive monitoring is also extremely necessary in situations where it is difficult to use complicated wired connections, such as ECG monitoring for infants, burn victims or during rescue missions when people are buried during building collapses/earthquakes. Due to the unique characteristics such as higher penetration capabilities, extremely precise ranging, low power requirement, low cost, simple hardware and robustness to multipath interferences, Impulse Radio Ultra Wideband (IR-UWB) technology is appropriate for non-invasive medical applications. IR-UWB sensors detect the macro as well as micro movement inside the human body due to its fine range resolution. The two vital signs, i.e., respiration rate and heart rate, can be measured by IR-UWB radar by measuring the change in the magnitude of signal due to displacement caused by human lungs, heart during respiration and heart beating. This paper reviews recent advances in IR- UWB radar sensor design for healthcare, such as vital signs measurements of a stationary human, vitals of a non-stationary human, vital signs of people in a vehicle, through the wall vitals measurement, neonate's health monitoring, fall detection, sleep monitoring and medical imaging. Although we have covered many topics related to health monitoring using IR-UWB, this paper is mainly focused on signal processing techniques for measurement of vital signs, i.e., respiration and heart rate monitoring.","Sensors (Basel)","Khan, Faheem","Ghaffar, Asim","Khan, Naeem","Cho, Sung Ho","32349382"],"abstract":["Non-invasive remote health monitoring plays a vital role in epidemiological situations such as SARS outbreak (2003), MERS (2015) and the recently ongoing outbreak of COVID-19 because it is extremely risky to get close to the patient due to the spread of contagious infections. Non-invasive monitoring is also extremely necessary in situations where it is difficult to use complicated wired connections, such as ECG monitoring for infants, burn victims or during rescue missions when people are buried during building collapses/earthquakes. Due to the unique characteristics such as higher penetration capabilities, extremely precise ranging, low power requirement, low cost, simple hardware and robustness to multipath interferences, Impulse Radio Ultra Wideband (IR-UWB) technology is appropriate for non-invasive medical applications. IR-UWB sensors detect the macro as well as micro movement inside the human body due to its fine range resolution. The two vital signs, i.e., respiration rate and heart rate, can be measured by IR-UWB radar by measuring the change in the magnitude of signal due to displacement caused by human lungs, heart during respiration and heart beating. This paper reviews recent advances in IR- UWB radar sensor design for healthcare, such as vital signs measurements of a stationary human, vitals of a non-stationary human, vital signs of people in a vehicle, through the wall vitals measurement, neonate's health monitoring, fall detection, sleep monitoring and medical imaging. Although we have covered many topics related to health monitoring using IR-UWB, this paper is mainly focused on signal processing techniques for measurement of vital signs, i.e., respiration and heart rate monitoring."],"journal":"Sensors (Basel)","authors":["Khan, Faheem","Ghaffar, Asim","Khan, Naeem","Cho, Sung Ho"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32349382","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/s20092479","keywords":["ir-uwb radar","algorithm","fall detection","heart rate","motion detection","respiration rate","sleep monitoring","vital signs"],"topics":["Prevention"],"weight":1,"_version_":1666138495760990208,"score":298.13803},{"pmid":32380846,"title":"The Canadian Association for Interventional Radiology (CAIR) and Canadian Association of Radiologists (CAR) Guidelines for Interventional Radiology Procedures for Patients With Suspected or Confirmed COVID-19.","text":["The Canadian Association for Interventional Radiology (CAIR) and Canadian Association of Radiologists (CAR) Guidelines for Interventional Radiology Procedures for Patients With Suspected or Confirmed COVID-19.","The current coronavirus disease 2019 (COVID-19) pandemic is creating significant challenges to the Canadian health system, including the practice of interventional radiology (IR). Interventional radiology will continue to play an important role in patient care, during this crisis. This document serves to guide interventional and general radiologists in safely performing IR procedures on patients with suspected or confirmed COVID-19, using the best evidence, guidelines and expert recommendations available. These strategies include reviewing procedural indications, development of tactics to minimize cross contamination prior to the intervention, appropriate usage of personal protection equipment according to the type of procedure (along with defining aerosol-generating procedures in IR), along with developing the appropriate work environment during the COVID-19 pandemic. By adopting the policies described, hospitals will protect the interventional radiologists, medical radiation technologists, nurses, ancillary staff, along with patients who benefit from their care.","Can Assoc Radiol J","Mujoomdar, Amol","Graham, Tara","Baerlocher, Mark Otto","Soulez, Gilles","32380846"],"abstract":["The current coronavirus disease 2019 (COVID-19) pandemic is creating significant challenges to the Canadian health system, including the practice of interventional radiology (IR). Interventional radiology will continue to play an important role in patient care, during this crisis. This document serves to guide interventional and general radiologists in safely performing IR procedures on patients with suspected or confirmed COVID-19, using the best evidence, guidelines and expert recommendations available. These strategies include reviewing procedural indications, development of tactics to minimize cross contamination prior to the intervention, appropriate usage of personal protection equipment according to the type of procedure (along with defining aerosol-generating procedures in IR), along with developing the appropriate work environment during the COVID-19 pandemic. By adopting the policies described, hospitals will protect the interventional radiologists, medical radiation technologists, nurses, ancillary staff, along with patients who benefit from their care."],"journal":"Can Assoc Radiol J","authors":["Mujoomdar, Amol","Graham, Tara","Baerlocher, Mark Otto","Soulez, Gilles"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32380846","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1177/0846537120924310","keywords":["covid-19","aerosol generating procedures","guidelines","interventional radiology","personal protective equipment"],"locations":["Canadian"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Prevention"],"weight":1,"_version_":1666419683251716097,"score":279.51514},{"pmid":32435882,"title":"Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.","text":["Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.","To face SARS-CoV-2 pandemic various attempts are made to identify potential effective treatments by repurposing available drugs. Among them, indomethacin, an anti-inflammatory drug, was shown to have potent in-vitro antiviral properties on human SARS-CoV-1, canine CCoV, and more recently on human SARS-CoV-2 at low micromolar range. Our objective was to show that indomethacin could be considered as a promising candidate for the treatment of SARS-CoV-2 and to provide criteria for comparing benefits of alternative dosage regimens using a model-based approach. A multi-stage model-based approach was developed to characterize % of recovery and viral load in CCoV-infected dogs, to estimate the PK of indomethacin in dog and human using published data after administration of immediate (IR) and sustained-release (SR) formulations, and to estimate the expected antiviral activity as a function of different assumptions on the effective exposure in human. Different dosage regimens were evaluated for IR formulation (25 mg and 50 mg three-times-a-day, and 25 mg four-times-a-day), and SR formulation (75 mg once and twice-a-day). The best performing dosing regimens were: 50 mg three-times-a-day for the IR formulation, and 75 mg twice-a-day for the SR formulation. The treatment with the SR formulation at the dose of 75 mg twice-a-day is expected to achieve a complete response in three days for the treatment in patients infected by the SARS-CoV-2 coronavirus. These results suggest that indomethacin could be considered as a promising candidate for the treatment of SARS-CoV-2 whose potential therapeutic effect need to be further assessed in a prospective clinical trial.","J Pharmacokinet Pharmacodyn","Gomeni, Roberto","Xu, Tianhong","Gao, Xuejuan","Bressolle-Gomeni, Francoise","32435882"],"abstract":["To face SARS-CoV-2 pandemic various attempts are made to identify potential effective treatments by repurposing available drugs. Among them, indomethacin, an anti-inflammatory drug, was shown to have potent in-vitro antiviral properties on human SARS-CoV-1, canine CCoV, and more recently on human SARS-CoV-2 at low micromolar range. Our objective was to show that indomethacin could be considered as a promising candidate for the treatment of SARS-CoV-2 and to provide criteria for comparing benefits of alternative dosage regimens using a model-based approach. A multi-stage model-based approach was developed to characterize % of recovery and viral load in CCoV-infected dogs, to estimate the PK of indomethacin in dog and human using published data after administration of immediate (IR) and sustained-release (SR) formulations, and to estimate the expected antiviral activity as a function of different assumptions on the effective exposure in human. Different dosage regimens were evaluated for IR formulation (25 mg and 50 mg three-times-a-day, and 25 mg four-times-a-day), and SR formulation (75 mg once and twice-a-day). The best performing dosing regimens were: 50 mg three-times-a-day for the IR formulation, and 75 mg twice-a-day for the SR formulation. The treatment with the SR formulation at the dose of 75 mg twice-a-day is expected to achieve a complete response in three days for the treatment in patients infected by the SARS-CoV-2 coronavirus. These results suggest that indomethacin could be considered as a promising candidate for the treatment of SARS-CoV-2 whose potential therapeutic effect need to be further assessed in a prospective clinical trial."],"journal":"J Pharmacokinet Pharmacodyn","authors":["Gomeni, Roberto","Xu, Tianhong","Gao, Xuejuan","Bressolle-Gomeni, Francoise"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435882","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s10928-020-09690-4","keywords":["clinical dose","indomethacin","model-based","sars-cov-2","translational model"],"e_drugs":["Indomethacin"],"topics":["Treatment"],"weight":1,"_version_":1667521393839833088,"score":276.8524},{"pmid":32340864,"pmcid":"PMC7142885","title":"COVID-19: What Should Interventional Radiologists Know and What Can They Do?","text":["COVID-19: What Should Interventional Radiologists Know and What Can They Do?","The outbreak of coronavirus disease 2019 (COVID-19) in late December 2019 in Wuhan, China, has been characterized as a \"pandemic\" by the World Health Organization and has resulted in 81,603 confirmed cases in China, among the 334,981 cases confirmed in 189 countries as of 09:00 am, March 24, 2020 (China central standard time). During the past 3 months, hundreds of thousands of Chinese health care workers, including interventional radiologists (IRs), have been fighting this battle against the horrifying COVID-19 disease. As IRs, what should we know and what can we do when facing this challenge? This paper shares the experience we have gone through.","J Vasc Interv Radiol","Zhu, Hai-Dong","Zeng, Chu-Hui","Lu, Jian","Teng, Gao-Jun","32340864"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) in late December 2019 in Wuhan, China, has been characterized as a \"pandemic\" by the World Health Organization and has resulted in 81,603 confirmed cases in China, among the 334,981 cases confirmed in 189 countries as of 09:00 am, March 24, 2020 (China central standard time). During the past 3 months, hundreds of thousands of Chinese health care workers, including interventional radiologists (IRs), have been fighting this battle against the horrifying COVID-19 disease. As IRs, what should we know and what can we do when facing this challenge? This paper shares the experience we have gone through."],"journal":"J Vasc Interv Radiol","authors":["Zhu, Hai-Dong","Zeng, Chu-Hui","Lu, Jian","Teng, Gao-Jun"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340864","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jvir.2020.03.022","locations":["Wuhan","China","China","China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138495774621696,"score":270.62915}]}